Table 6.

Relative reduction of mortality associated with prescription of a β-blocker, per age ^*

	Adjusted
Variable	HR	95% CI
Age (years)
65	0.31	0.15, 0.64
70	0.38	0.20, 0.71
75	0.47	0.26, 0.83
80	0.57	0.32, 1.02
85	0.70	0.37, 1.34

^*Adjusted for gender, New York Heart Association class, ejection fraction, mean arterial pressure, chronic obstructive pulmonary disease, sodium serum, glomerular filtration rate, concomitant medication and propensity scores for β-blocker use.